Suppr超能文献

KPNB1 抑制破坏了蛋白质平衡,并触发了神经胶质瘤细胞中未折叠蛋白反应介导的细胞凋亡。

KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.

机构信息

Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, 200031, Shanghai, China.

School of Pharmacy, East China University of Science and Technology, 200237, Shanghai, China.

出版信息

Oncogene. 2018 May;37(22):2936-2952. doi: 10.1038/s41388-018-0180-9. Epub 2018 Mar 9.

Abstract

The nuclear import receptor karyopherin β1 (KPNB1) is involved in the nuclear import of most proteins and in the regulation of multiple mitotic events. Upregulation of KPNB1 has been observed in cancers including glioblastoma. Depletion of KPNB1 induces mitotic arrest and apoptosis in cancer cells, but the underlying mechanism is not clearly elucidated. Here, we found that downregulation and functional inhibition of KPNB1 in glioblastoma cells induced growth arrest and apoptosis without apparent mitotic arrest. KPNB1 inhibition upregulated Puma and Noxa and freed Mcl-1-sequestered Bax and Bak, leading to mitochondrial outer membrane permeabilization (MOMP) and apoptosis. Moreover, combination of Bcl-xL inhibitors and KPNB1 inhibition enhanced apoptosis in glioblastoma cells. KPNB1 inhibition promoted cytosolic retention of its cargo and impaired cellular proteostasis, resulting in elevated polyubiquitination, formation of aggresome-like-induced structure (ALIS), and unfolded protein response (UPR). Ubiquitination elevation and UPR activation in KPNB1-deficient cells were reversed by KPNB1 overexpression or inhibitors of protein synthesis but aggravated by inhibitors of autophagy-lysosome or proteasome, indicating that rebalance of cytosolic/nuclear protein distribution and alleviation of protein overload favor proteostasis and cell survival. Chronic activation of eIF2α/ATF4 cascade of UPR was responsible for the upregulation of Puma and Noxa, apoptosis and ABT-263 sensitivity. Taken together, our findings demonstrate that KPNB1 is required for proteostasis maintenance and its inhibition induces apoptosis in glioblastoma cells through UPR-mediated deregulation of Bcl-2 family members.

摘要

核输入受体载体蛋白β1(KPNB1)参与大多数蛋白质的核输入和多种有丝分裂事件的调节。在包括神经胶质瘤在内的多种癌症中观察到 KPNB1 的上调。KPNB1 的耗竭会诱导癌细胞有丝分裂停滞和凋亡,但潜在机制尚不清楚。在这里,我们发现下调和功能抑制神经胶质瘤细胞中的 KPNB1 会诱导生长停滞和凋亡,而没有明显的有丝分裂停滞。KPNB1 抑制上调 Puma 和 Noxa,并释放 Mcl-1 结合的 Bax 和 Bak,导致线粒体外膜通透性(MOMP)和凋亡。此外,Bcl-xL 抑制剂和 KPNB1 抑制的联合使用增强了神经胶质瘤细胞的凋亡。KPNB1 抑制促进了其货物的细胞质保留,并损害了细胞内的蛋白质稳态,导致多泛素化增加、形成聚集诱导结构(ALIS)和未折叠蛋白反应(UPR)。KPNB1 缺陷细胞中的泛素化升高和 UPR 激活可被 KPNB1 过表达或蛋白质合成抑制剂逆转,但可被自噬溶酶体或蛋白酶体抑制剂加重,表明细胞质/核蛋白质分布的再平衡和蛋白质过载的缓解有利于蛋白质稳态和细胞存活。UPR 中 eIF2α/ATF4 级联的慢性激活负责 Puma 和 Noxa 的上调、凋亡和 ABT-263 敏感性。总之,我们的研究结果表明,KPNB1 是维持蛋白质稳态所必需的,其抑制通过 UPR 介导的 Bcl-2 家族成员失调诱导神经胶质瘤细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/396f/5978811/a566b194adbf/41388_2018_180_Fig1_HTML.jpg

相似文献

1
KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.
Oncogene. 2018 May;37(22):2936-2952. doi: 10.1038/s41388-018-0180-9. Epub 2018 Mar 9.
2
Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells.
Cell Death Dis. 2019 Feb 11;10(2):118. doi: 10.1038/s41419-019-1383-x.
4
KPNB1-mediated nuclear import in cancer.
Eur J Pharmacol. 2023 Sep 15;955:175925. doi: 10.1016/j.ejphar.2023.175925. Epub 2023 Jul 18.
6
Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Mol Cancer Res. 2015 Apr;13(4):659-69. doi: 10.1158/1541-7786.MCR-14-0476. Epub 2014 Dec 29.
7
Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.
J Exp Clin Cancer Res. 2024 Jan 23;43(1):28. doi: 10.1186/s13046-024-02954-8.
8
Combined inhibition of RAC1 and Bcl-2/Bcl-xL synergistically induces glioblastoma cell death through down-regulation of the Usp9X/Mcl-1 axis.
Cell Oncol (Dordr). 2019 Jun;42(3):287-301. doi: 10.1007/s13402-019-00425-3. Epub 2019 Mar 11.

引用本文的文献

1
The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanism.
Sci Rep. 2025 Jul 1;15(1):22067. doi: 10.1038/s41598-025-03419-4.
3
VCP's nuclear journey: Initiated by interacting with KPNB1 to repair DNA damage.
Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2416045122. doi: 10.1073/pnas.2416045122. Epub 2025 May 8.
5
Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma.
Int J Mol Sci. 2024 Jul 9;25(14):7506. doi: 10.3390/ijms25147506.
6
Astragaloside Ⅳ mediates the effect and mechanism of KPNB1 on biological behavior and tumor growth in prostate cancer.
Heliyon. 2024 Jun 28;10(13):e33904. doi: 10.1016/j.heliyon.2024.e33904. eCollection 2024 Jul 15.
8
Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.
J Exp Clin Cancer Res. 2024 Jan 23;43(1):28. doi: 10.1186/s13046-024-02954-8.
9
ADAMTS-1 has nuclear localization in cells with epithelial origin and leads to decreased cell migration.
Exp Cell Res. 2023 Dec 15;433(2):113852. doi: 10.1016/j.yexcr.2023.113852. Epub 2023 Nov 10.

本文引用的文献

1
Measurement of BH3-only protein tolerance.
Cell Death Differ. 2018 Feb;25(2):282-293. doi: 10.1038/cdd.2017.156. Epub 2017 Oct 20.
2
Targeting BCL-2-like Proteins to Kill Cancer Cells.
Trends Cancer. 2016 Aug;2(8):443-460. doi: 10.1016/j.trecan.2016.07.001. Epub 2016 Jul 30.
3
Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic.
Mol Cancer Ther. 2016 Apr;15(4):560-73. doi: 10.1158/1535-7163.MCT-15-0052. Epub 2016 Feb 1.
4
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development.
J Hematol Oncol. 2015 Nov 20;8:129. doi: 10.1186/s13045-015-0224-3.
5
Targeting BCL2-Proteins for the Treatment of Solid Tumours.
Adv Med. 2014;2014:943648. doi: 10.1155/2014/943648. Epub 2014 Aug 27.
7
ER stress: Autophagy induction, inhibition and selection.
Autophagy. 2015 Nov 2;11(11):1956-1977. doi: 10.1080/15548627.2015.1091141.
8
Hyper-dependence of breast cancer cell types on the nuclear transporter Importin β1.
Biochim Biophys Acta. 2015 Aug;1853(8):1870-8. doi: 10.1016/j.bbamcr.2015.05.002. Epub 2015 May 8.
9
CHOP mediates XBP1S-induced renal mesangial cell necrosis following high glucose treatment.
Eur J Pharmacol. 2015 Jul 5;758:89-96. doi: 10.1016/j.ejphar.2015.03.069. Epub 2015 Apr 6.
10
Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.
Med Oncol. 2015 Apr;32(4):128. doi: 10.1007/s12032-015-0559-1. Epub 2015 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验